Long-Term Overall Survival (OS) with Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Updated Results from the Phase 3 QUAZAR AML-001 Trial -
NEJM on X: "Original Article: Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma https://t.co/0pcpqYVD59 https://t.co/Gheb94m7pa" / X
UK cancer survival rates trail 10 years behind other European countries | Cancer | The Guardian
POR | Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry